Molecular and Genetic Mechanisms Involved in the Pathogenesis of Cardiorenal Cross Talk

Grazia Maria Virzì1, Anna Clementi, Alessandra Brocca

  • 1Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, Vicenza, Italy.

Insights

Cardiorenal syndrome involves heart and kidney dysfunction. This review explores novel epigenetic and genetic factors contributing to cardiorenal crosstalk and disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Genetics

Background:

  • Cardiorenal syndrome (CRS) describes the co-occurrence of cardiac and renal dysfunction.
  • Established mechanisms include inflammation, oxidative stress, apoptosis, and immune dysregulation.
  • The intricate crosstalk between the heart and kidneys is not fully understood.

Purpose of the Study:

  • To review emerging mechanisms in cardiorenal crosstalk.
  • Focus on epigenetics, prenatal programming, noncoding RNAs, and extracellular vesicles.
  • Elucidate their potential roles in heart and kidney diseases.

Main Methods:

  • Literature review of recent research.
  • Analysis of studies investigating novel molecular pathways.
  • Synthesis of findings on cardiorenal interactions.

Main Results:

  • Epigenetic modifications, prenatal programming, small noncoding RNAs, and extracellular vesicles are implicated in CRS pathogenesis.
  • These factors offer new perspectives on the complex heart-kidney axis.
  • Understanding these mechanisms could reveal therapeutic targets.

Conclusions:

  • Emerging mechanisms like epigenetics and noncoding RNAs significantly contribute to cardiorenal crosstalk.
  • Further research into these pathways is crucial for advancing CRS understanding and treatment.
  • These novel factors represent a paradigm shift in studying heart and kidney disease interactions.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K